Citation 78214

MIMAKI,Y: KURODA,M: KAMEYAMA,A: SASHIDA,Y: HIRANO,T: OKA,K: MAEKAWA,R: WADA,T: SUGITA,K: BEUTLER,JA:. (1997). CHOLESTANE GLYCOSIDES WITH POTENT CYTOSTATIC ACTIVITIES ON VARIOUS TUMOR CELLS FROM ORNITHOGALUM SAUNDERSIAE BULBS.. 7(5)

Citation Details

TitleCHOLESTANE GLYCOSIDES WITH POTENT CYTOSTATIC ACTIVITIES ON VARIOUS TUMOR CELLS FROM ORNITHOGALUM SAUNDERSIAE BULBS.
AuthorsMIMAKI,Y: KURODA,M: KAMEYAMA,A: SASHIDA,Y: HIRANO,T: OKA,K: MAEKAWA,R: WADA,T: SUGITA,K: BEUTLER,JA:
Year1997
Volume7
Issue5

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Ornithogalum saundersiae (LILIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
None
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
8
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-XYLOPYRANOSIDE]
STRONG ACTIVITY
13Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE]
None
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE]
STRONG ACTIVITY
15Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-TRANS-CINNAMOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE]
None
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 16-O-[O-(2-TRANS-CINNAMOYL-BETA-D-XYLOPYRANOSYL)(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE]
STRONG ACTIVITY
17Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSIDE-16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE]
None
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSIDE-16-O-[O-(2-O-4-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE]
STRONG ACTIVITY
19Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSIDE-16-O-[O-(2-TRANS-CINNAMOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE]
None
20
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLEST-5-EN-22-ONE,3-BETA-16-BETA-17-ALPHA-TRIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSIDE-16-O-[O-(2-TRANS-CINNAMOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE]
STRONG ACTIVITY
Show SPARQL Queries (1)